RE: RNS - Tim McCarthy, CEO and Chairman, said: "ImmuPharma is entering a pivotal phase, focused on securing a commercial partnership for P14027 May 2026 08:31
I have been a holder for a number of years. The amount of CEOs of AIM companies in particular who lie to shareholders and when it all goes wrong just walk away is criminal. Mr McCarthy is just another in this long list. When asked at the last raise if he was putting his hand in his pocket to buy the offering, response was silence.